Verrica Pharmaceuticals Inc. (VRCA)
5.70
+0.26 (4.78%)
Upcoming Events
Latest Headlines
Verrica Pharma signs Israel deal for skin disease treatment YCANTH
July 21, 2026 8:00 AM - StreetInsider
Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel
July 21, 2026 8:00 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on Verrica Pharmaceuticals (VRCA)
June 23, 2026 6:53 AM - StreetInsider
Verrica doses first U.S. patient in COVE-3 trial for common warts
June 22, 2026 8:05 AM - StreetInsider
Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
June 22, 2026 8:05 AM - StreetInsider
Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Nguyen Diem
June 9, 2026 4:16 PM - SEC Filing
Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Eichenfield Lawrence
June 9, 2026 4:16 PM - SEC Filing
Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: PRYGOCKI MARK A SR
June 9, 2026 4:16 PM - SEC Filing
Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Rosenberg Noah L.
June 9, 2026 4:16 PM - SEC Filing
Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Rieger Jayson
June 9, 2026 4:15 PM - SEC Filing
Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Zawitz David
June 9, 2026 4:15 PM - SEC Filing
Form 4 Verrica Pharmaceuticals For: Jun 05 Filed by: Corcoran Gavin
June 9, 2026 4:15 PM - SEC Filing
Form 8-K Verrica Pharmaceuticals For: Jun 05
June 9, 2026 4:06 PM - SEC Filing
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
May 28, 2026 8:05 AM - StreetInsider
H.C. Wainwright Assumes Verrica Pharmaceuticals (VRCA) at Buy
May 26, 2026 6:15 AM - StreetInsider
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
May 13, 2026 8:00 AM - Globe NewsWire
Form S-8 Verrica Pharmaceuticals
May 12, 2026 5:30 PM - SEC Filing
Verrica Pharmaceuticals Inc. (VRCA) Misses Q1 EPS by 41c
May 12, 2026 5:05 PM - StreetInsider
Form 10-Q Verrica Pharmaceuticals For: Mar 31
May 12, 2026 4:16 PM - SEC Filing
Form 8-K Verrica Pharmaceuticals For: May 12
May 12, 2026 4:08 PM - SEC Filing
Verrica Pharmaceuticals Reports First Quarter 2026 Financial Results
May 12, 2026 4:01 PM - StreetInsider
Verrica to present VP-315 basal cell carcinoma data at dermatology meeting
May 5, 2026 4:06 PM - StreetInsider
Verrica Pharmaceuticals Announces Upcoming Presentation of Phase 2 Data Highlighting the Potential Abscopal Effects of VP-315 in the Treatment of Basal Cell Carcinoma at the 2026 Society for Investiga
May 5, 2026 4:05 PM - Globe NewsWire
Verrica Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide a Corporate Update on May 12, 2026
May 5, 2026 8:00 AM - Globe NewsWire
Full Article List
